Exane Derivatives’s Talend S.A. American Depositary Shares TLND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-57
Closed -$3.73K 1095
2021
Q2
$3.73K Hold
57
﹤0.01% 787
2021
Q1
$3.63K Buy
+57
New +$2.96K ﹤0.01% 639

Exane Derivatives's TLND Position: Q3 2021 in Review

Exane Derivatives sold out of Talend S.A. American Depositary Shares (TLND) in Q3 2021, closing a stake of 57 shares — an estimated $3.73K sold.

Exane Derivatives first reported a position in TLND in Q1 2021 and held it in 2 quarters. The position peaked at $3.73K in Q2 2021. 0 funds tracked by Wall St. Rank hold TLND as of Q3 2021.

  • Exane Derivatives reported no remaining Talend S.A. American Depositary Shares position as of Q3 2021 after selling out during the quarter.
  • Exane Derivatives sold 57 Talend S.A. American Depositary Shares shares in Q3 2021, an estimated $3.73K.
  • Exane Derivatives first reported a position in Talend S.A. American Depositary Shares in Q1 2021 and held it in 2 quarters.
  • Exane Derivatives's Talend S.A. American Depositary Shares position peaked at $3.73K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Talend S.A. American Depositary Shares as of Q3 2021.

Based on Exane Derivatives's 13F filing for Q3 2021, filed 26 Oct 2021.